Insider Transactions in Q4 2021 at Maravai Lifesciences Holdings, Inc. (MRVI)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,570,415
-2.04%
|
-
|
|
Nov 19
2021
|
Sean Laurence Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+12.07%
|
-
|
|
Nov 19
2021
|
Luke Joseph Marker Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Benjamin James Daverman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Anat Ashkenazi Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+20.94%
|
-
|
|
Nov 19
2021
|
Constantine S Mihas Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Susannah Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+10.57%
|
-
|
|
Nov 19
2021
|
Robert B Hance Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+14.05%
|
-
|
|
Nov 19
2021
|
Jessica Hopfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+6.07%
|
-
|
|
Nov 19
2021
|
Murali Prahalad Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+11.12%
|
-
|
|
Oct 31
2021
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
203
+15.36%
|
$4,466
$22.95 P/Share
|
|
Oct 31
2021
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
542
+5.97%
|
$11,924
$22.95 P/Share
|
|
Oct 31
2021
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
598
+40.35%
|
$13,156
$22.95 P/Share
|
|
Oct 31
2021
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
392
+30.6%
|
$8,624
$22.95 P/Share
|